Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Polymyositis and dermatomyositis

MC Dalakas, R Hohlfeld - The Lancet, 2003 - thelancet.com
The inflammatory myopathies, commonly described as idiopathic, are the largest group of
acquired and potentially treatable myopathies. On the basis of unique clinical …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high‐dose glucocorticoid, tacrolimus, and cyclophosphamide in …

H Tsuji, R Nakashima, Y Hosono, Y Imura… - Arthritis & …, 2020 - Wiley Online Library
Objective Interstitial lung disease (ILD) accompanied by anti–melanoma differentiation–
associated gene 5 (anti–MDA‐5)–positive dermatomyositis (DM) is often rapidly progressive …

Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

J Schwartz, JL Winters, A Padmanabhan… - Journal of clinical …, 2013 - Wiley Online Library
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …

119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003 …

JE Hoogendijk, AA Amato, BR Lecky, EH Choy… - Neuromuscular …, 2004 - Elsevier
Polymyositis (PM) and dermatomyositis (DM) are idiopathic inflammatory myopathies (IIMs)
with an autoimmune pathogenesis. Typical features are subacute-onset, proximal …

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

MC Dalakas, I Illa, JM Dambrosia… - … England Journal of …, 1993 - Mass Medical Soc
Background Dermatomyositis is a clinically distinct myopathy characterized by rash and a
complement-mediated microangiopathy that results in the destruction of muscle fibers. In …

Users' guides to the medical literature: IX. A method for grading health care recommendations

GH Guyatt, DL Sackett, JC Sinclair, R Hayward… - Jama, 1995 - jamanetwork.com
THE ULTIMATE PURPOSE of applied health research is to improve health care.
Summarizing the literature to adduce recommendations for clinical practice is an important …

Users' guides to the medical literature: II. How to use an article about therapy or prevention A. Are the results of the study valid?

GH Guyatt, DL Sackett, DJ Cook, G Guyatt, E Bass… - Jama, 1993 - jamanetwork.com
CLINICAL SCENARIO You are working as an internal medicine resident in a rheumatology
rotation and are seeing a 19-year-old woman who has had systemic lupus erythematosus …

Dermatomyositis

JP Callen - The Lancet, 2000 - thelancet.com
Dermatomyositis is one of the idiopathic inflammatory myopathies with characteristic
cutaneous manifestations including the heliotrope rash, Gottron's papules, cuticular changes …